| 1 |
Nobre SR, Cabral JE, Gomes JJ, et al. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model[J]. Eur J Gastroenterol Hepatol, 2008, 20 (12): 1176-1181.
|
| 2 |
Toledo C, Salmerón JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime[J]. Hepatology, 1993, 17 (2): 251-257.
|
| 3 |
Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis[J]. Hepatology, 2002, 35 (1): 140-148.
|
| 4 |
Altman C, Grangé JD, Amiot X, et al. Survival after a frst episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation[J]. J Gastroenterol Hepatol, 1995, 10 (1): 47-50.
|
| 5 |
Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections[J]. Clin Gastroenterol Hepatol, 2010, 8 (11): 979-985.
|
| 6 |
Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia[J]. Ann Intern Med, 2009, 150 (1): 19-26.
|
| 7 |
Kim SU, Chon YE, Lee CK, et al. Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial[J]. Yonsei Med J, 2012, 53 (2): 328-336.
|
| 8 |
Lutz P, Nischalke HD, Kramer B, et al. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis[J]. Eur J Clin Invest, 2017, 47 (1): 44-52.
|
| 9 |
科技部十二五重大专项联合课题组专家. 乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J]. 中华肝脏病杂志，2014，22(5):327-335.
|
| 10 |
Schwabl P, Bucsics T, Soucek K, et al. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites[J]. Liver Int, 2015, 35 (9): 2121-2128.
|
| 11 |
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33 (2): 464-470.
|
| 12 |
郑盛，殷芳，严晓会，等. MELD-Na模型评分对评估失代偿期肝硬化患者短期预后的临床价值[J]. 实用肝脏病杂志，2009，12(2):118-120.
|
| 13 |
Piroth L, Pechinot A, Di Martino V, et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study[J]. BMC Infect Dis, 2014 (14): 287.
|
| 14 |
Li YT, Yu CB, Huang JR, et al. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients[J]. World J Gastroenterol, 2015, 21 (36): 10409-10417.
|
| 15 |
Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012[J]. Hepatology, 2013, 57 (4): 1651-1653.
|
| 16 |
Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond[J]. Gut, 2012, 61 (2): 297-310.
|
| 17 |
Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial[J]. Hepatology, 2016, 63 (4): 1299-1309.
|